MedPath

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Not Applicable
Completed
Conditions
Sepsis
Respiratory Failure
Renal Failure
Surgical Site Infection
Registration Number
NCT00282594
Lead Sponsor
Genesys
Brief Summary

We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.

Detailed Description

While evidence exists for using tight glycemic control in the critically ill cardiac surgical patient, other patient populations have yet to be studied. We performed a prospective randomized trial for using intensive insulin therapy in the general and vascular critically ill surgical patient population. We will compare tight glycemic control versus conventional glycemic control to determine if there is a benefit to the normalization of blood glucose levels in this patient population

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
317
Inclusion Criteria

Patients undergoing a general or vascular surgical procedure requiring admission to the surgical intensive care unit as a result of ventilatory requirement, vasopressor support, or physiologic instability

Exclusion Criteria
  • Under age 18

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mortality
Secondary Outcome Measures
NameTimeMethod
Length of ICU Stay
Ventilatory Requirement
Vasopressor Support
Incidence of Renal Failure
Incidence of Wound Infection

Trial Locations

Locations (1)

Genesys Regional Medical Center

🇺🇸

Grand Blanc, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath